MacAndrews & Forbes
MacAndrews & Forbes is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at MacAndrews & Forbes.
MacAndrews & Forbes is a company.
Key people at MacAndrews & Forbes.
MacAndrews & Forbes Incorporated is a private investment holding company controlled by billionaire Ronald O. Perelman, focusing on full or majority ownership stakes in a diversified portfolio of public and private companies across industries like consumer products, biotech, media, gaming, retail, and financial services.[2][6] Its mission centers on long-term value creation through strategic acquisitions, often via leveraged buyouts and hostile takeovers, with key sectors including beauty (e.g., Revlon), biotech (e.g., SIGA Technologies, vTv Therapeutics), advertising (e.g., Vericast), and manufacturing (e.g., licorice via MAFCO).[2][6] Unlike venture capital firms targeting startups, MacAndrews & Forbes emphasizes controlling interests in established businesses, providing operational support and leveraging Perelman's network for growth, though it has limited direct impact on the startup ecosystem beyond occasional investments in mature tech-adjacent firms like RetailMeNot.[2]
The roots trace to 1850, when MacAndrews & Forbes Co. was founded by Edward MacAndrews and William Forbes (or linked to Robert McAndrew's shipping ventures) as a licorice extract manufacturer and distributor, initially based in Smyrna, Asia Minor, and later Newark, New Jersey, prospering through exports to industries like tobacco and confectionery.[1][4][5] The modern iteration emerged in 1980 when Ronald O. Perelman, starting with a small loan in 1978, acquired the company for $45.7 million via Cohen-Hatfield, using it as the vehicle for his empire-building through 1980s-style aggressive tactics like junk bonds and takeovers.[3][4] Perelman, born in 1943 and Wharton-educated, evolved the firm from licorice dominance (e.g., 70% global market share by 1999) into a multi-industry holding company, with pivotal moments including the 1983 formation of MacAndrews & Forbes Holdings, acquisitions like Revlon and Marvel, and banking ventures like First Nationwide.[1][2][3]
MacAndrews & Forbes rides trends in biotech innovation (e.g., SIGA's antivirals, vTv's therapeutics) and digital transformation (e.g., Vericast's advertising tech from RetailMeNot/Valassis), capitalizing on post-2000 shifts from pure manufacturing to tech-enabled services amid regulatory favors like S&L bailouts.[2][3][6] Timing aligns with 1980s deregulation enabling junk bond-fueled empires and 21st-century biotech booms, bolstered by market forces like tobacco's licorice demand (73% of sales in 2005) and adtech consolidation.[1] It influences the ecosystem indirectly by stabilizing acquired tech firms (e.g., SciGames gaming, Technicolor media) through Perelman's capital, though its private nature limits broader startup disruption compared to VC giants like KKR.[2]
MacAndrews & Forbes remains a Perelman-centric powerhouse, likely prioritizing biotech expansions (SIGA, vTv) and consumer resilience amid economic volatility, with trends like AI-driven ads and pandemic preparedness favoring its portfolio.[2][6] Influence may evolve toward deeper tech integrations in holdings like Vericast, potentially via selective M&A, sustaining its contrarian, control-oriented edge in a startup-dominated landscape—echoing its 1850 licorice origins now amplified by modern dealmaking.
Key people at MacAndrews & Forbes.
